Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Telcagepant NCT00662818 · Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular… | Migraine | À vérifier | Phase 3 | COMPLETED | The purpose of this study is to evaluate the safety and efficacy of telcag… À vérifier | ClinicalTrials.gov 2026-07-29 15:50:52 | Détail |
| The Effect of Wet Cupping Therapy on Headache and Migraine-related Di… NCT06568757 · NCT06568757 | Migraine | Ralentissement de la progression | NA | NOT_YET_RECRUITING | Objective: This study aims to investigate the effects of wet cupping thera… À vérifier | ClinicalTrials.gov 2026-07-29 15:50:52 | Détail |
| Propranolol 160 mg Étude non communiquée | Migraine | À vérifier | Phase 4 | Actif | This goal of this study is to compare three medications used for migraine… À vérifier | ClinicalTrials.gov 2026-07-29 | Détail |
| Topiramate 100 mg Étude non communiquée | Migraine | À vérifier | Phase 4 | Actif | This goal of this study is to compare three medications used for migraine… À vérifier | ClinicalTrials.gov 2026-07-29 | Détail |
| Transcatheter Closure of Patent Foramen Ovale Étude non communiquée | Migraine | À vérifier | Phase 3 | Prévu | Migraine is a common and often disabling condition, but its exact causes a… À vérifier | ClinicalTrials.gov 2026-07-28 | Détail |
| BioSTAR Septal Repair Implant System NCT00283738 · MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant | Migraine | À vérifier | Phase 2 | UNKNOWN | The objective of the study is to investigate the safety and effectiveness… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:24 | Détail |
| ALD403 NCT01772524 · Safety, Efficacy and Pharmacokinetics of ALD403 | Migraine | À vérifier | Phase 1 | COMPLETED | The purpose of this study is to assess the safety, pharmacokinetics and ef… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:23 | Détail |
| Aspirin (acetylsalicylic acid) NCT01257893 · ARWM — Aspirin Resistance in Women With Migraine | Migraine | Traitement symptomatique | NA | WITHDRAWN | The purpose of this study is to compare the rates of aspirin resistance (h… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:23 | Détail |
| Botulinum toxin type A NCT02147561 · A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine | Migraine | Traitement symptomatique | Phase 4 | COMPLETED | The main purpose of this study is to determine which is the best dose of a… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:23 | Détail |
| eletriptan NCT00634985 · Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsu… | Migraine | Immunomodulation | Phase 4 | COMPLETED | To assess the safety and efficacy of eletriptan for the treatment of migra… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:23 | Détail |
| Elexir (program1) NCT06170411 · Post-marketing Clinical Trial of Elexir(Trigeminal Nerve Electrical Stimulator)… | Migraine | À vérifier | NA | UNKNOWN | The purpose of this study is to evaluate the efficacy and safety of treati… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:23 | Détail |
| Flow Detection System NCT01773252 · PFO Detection — Right to Left Cardiac Shunt Detection | Migraine | Thérapie génique | Phase 3 | TERMINATED | The purpose of this study is to evaluate the sensitivity and specificity o… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:23 | Détail |
| MPL-001 NCT05337033 · Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial | Migraine | Ralentissement de la progression · Traitement symptomatique | Phase 2 | RECRUITING | Chronic headaches are a major cause of disability among adolescents. Canna… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:23 | Détail |
| PREDI-CRISIS — Migraine Attack Pain Phase Prediction Study NCT06459635 · NCT06459635 | Migraine | Traitement symptomatique | À vérifier | RECRUITING | The study of the ability to predict pain in a migraine attack, through pre… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:23 | Détail |
| The Role Of Vestibular Rehabilitation Therapy In Management Of Vestib… NCT05508139 · NCT05508139 | Migraine | À vérifier | À vérifier | UNKNOWN | 1. To assess the criteria of positional vertigo in vestibular migraine pat… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:23 | Détail |
| Calcitonin Gene-Related Peptide NCT03481400 · CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal An… | Migraine | À vérifier | NA | UNKNOWN | The investigators aim to investigate the incidence of migraine attacks aft… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:22 | Détail |
| MR-angiography, GTN NCT00256802 · The Diameter of the Middle Cerebral Artery Measured With Magnetic Resonance Angi… | Migraine | À vérifier | NA | COMPLETED | To examine the ability of MRA to measure the effect of GTN on the intra-cr… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:22 | Détail |
| PFO occlusion NCT06033937 · COMPETE Cohort Study | Migraine | Traitement symptomatique | À vérifier | UNKNOWN | Migraine attacks are episodic disorder that affects approximately 12% of t… À vérifier | ClinicalTrials.gov 2026-07-24 10:34:22 | Détail |
| Botulinum toxin type A NCT06448676 · Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabella… | Migraine | Traitement symptomatique | Phase 4 | RECRUITING | The main purpose of this study is to determine which is the best dose of a… À vérifier | ClinicalTrials.gov 2026-07-23 12:24:01 | Détail |
| Botulinum toxin type A NCT00301665 · Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis | Migraine | Traitement symptomatique | Phase 2 | COMPLETED | The main purpose of this study is to determine which is the best dose of a… À vérifier | ClinicalTrials.gov 2026-07-23 12:24:01 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Case Report: Anodal DLPFC-tDCS for refractory post-traumatic cognitiv… Galcanezumab · PMID 42602261 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Cognitive fatigue is among the most common and disabling long-term sequelae of mild traumatic brain injury (mTBI), with… | Frontiers in human neuroscience 2026-08-16 19:23:06 | Source |
| High Cervical 10 kHz Spinal Cord Stimulation After Occipital Nerve St… Occipital Nerve Stimulation · PMID 42573543 | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source In this retrospective study, we evaluated high-frequency spinal cord stimulation (SCS) as an alternative neuromodulatio… | Neuromodulation : journal of the International Neuromo… 2026-08-16 19:23:03 | Source |
| Global prevalence and disability burden of brain disorders: Impact of… BE WELL With Migraine: Brain Education and WELLness With Migraine · PMID 42269957 | Migraine | Ralentissement de la progression | Publication | PubMed | Voir la publication source Brain disorders-encompassing neurological, mental, and substance use disorders-account for 10 of the top 25 causes of d… | Neuroscience and biobehavioral reviews 2026-08-16 19:22:56 | Source |
| NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist,… NXN-188 · PMID 23155193 | Migraine | À vérifier | Publication | PubMed | Voir la publication source NXN-188 is a combined neuronal nitric oxide synthase (nNOS) inhibitor and 5-hydroxytryptamine 1B/1D (5-HT1B/1D) recepto… | Cephalalgia : an international journal of headache 2026-08-16 19:22:51 | Source |
| Vestibular cortex-related effective connectivity signatures: characte… Vestibular System in Migrainous Vertigo Patients · PMID 42337425 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Neuroimaging studies of vestibular migraine (VM) have revealed abnormal functional connectivity in the central vestibul… | The journal of headache and pain 2026-08-16 19:22:46 | Source |
| Cultured Epidermal Autograft Formation With Reduced Platelet-Rich Pla… blood withdrawal · PMID 42424623 | Migraine | Immunomodulation | Publication | PubMed | Voir la publication source Cultured epidermal autografts (CEA) reportedly have better cosmesis than traditional autografts and are especially usef… | The Journal of craniofacial surgery 2026-08-16 19:22:45 | Source |
| Impact of acute high thoracic spinal cord injury on in vivo vascular… blood withdrawal · PMID 42219075 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Cardiovascular dysfunction is a major cause of morbidity and mortality following high-thoracic spinal cord injury (SCI)… | Experimental neurology 2026-08-16 19:22:45 | Source |
| Practice-Based Consensus Amongst Indian Neurologists: Adopting Remote… Nerivio ® · PMID 41697517 | Migraine | Ralentissement de la progression | Publication | PubMed | Voir la publication source Migraine is a major cause of disability in India, disproportionately affecting women and adolescents. Although traditio… | Advances in therapy 2026-08-16 19:22:41 | Source |
| Ultrasound-guided 5-in-1 trigger point injection for treating tension… Greater Occipital Nerve Block with 0.9% saline · PMID 35945722 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Tension-type headache (TTH) is the most common type of primary headache, and trigger point injection (TPI) is frequentl… | Medicine 2026-08-16 19:22:37 | Source |
| The consequences of the new European reclassification of non-invasive… tDCS device from neuroConn · PMID 38679530 | Migraine | À vérifier | Publication | PubMed | Voir la publication source A significant amount of European basic and clinical neuroscience research includes the use of transcranial magnetic sti… | Clinical neurophysiology : official journal of the Int… 2026-08-16 19:22:35 | Source |
| Prescription of cardiovascular drugs in the French ODIN cohort of hea… Part A: TRV250-20mg/ml · PMID 24388162 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Chronic heart failure (CHF) is a frequent severe disease. Disease-management programmes, which contain a therapeutic pa… | Archives of cardiovascular diseases 2026-08-16 19:22:24 | Source |
| Socioeconomic factors and mortality in diastolic heart failure. Part A: TRV250-20mg/ml · PMID 24467732 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Mortality in patients with heart failure with preserved ejection fraction (HFPEF) has remained stable over recent decad… | European journal of clinical investigation 2026-08-16 19:22:24 | Source |
| [Neurostimulation of the supraorbital nerve with the Cefaly device -… Cefaly device · PMID 31089108 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Treatment of migraine mainly includes pharmacological approaches aimed at breaking migraine attacks and preventive trea… | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2026-08-16 19:22:19 | Source |
| Management of refractory chronic migraine using ultrasound-guided pul… Efficacy of Greater Occipital Nerve Radiofrequency for Refractory Migraine Treatment · PMID 30… | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Although various oral medications and procedures are applied for managing migraine, their efficacy remains limited. To… | Medicine 2026-08-16 19:22:18 | Source |
| Comparative efficacy, quality of life, safety, and tolerability of at… Rimegepant/BHV3000 · PMID 38410850 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Comparative evaluations of preventive migraine treatments can help inform clinical decision making for managing migrain… | Cephalalgia : an international journal of headache 2026-08-16 19:22:17 | Source |
| Cost per treatment responder analysis of atogepant compared to rimege… Rimegepant/BHV3000 · PMID 39248007 | Migraine | À vérifier | Publication | PubMed | Voir la publication source To estimate the number needed to treat and cost per additional responder for atogepant and rimegepant versus placebo fo… | Headache 2026-08-16 19:22:17 | Source |
| Pharmacological interventions for antipsychotic-induced weight gain i… Topiramate 100 mg · PMID 38878592 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Antipsychotic-induced weight gain (AIWG) is a significant but frequently neglected adverse effect of first- and second-… | General hospital psychiatry 2026-08-16 19:22:16 | Source |
| Propranolol Versus Metoprolol for Treatment of Electrical Storm in Pa… Propranolol 160 mg · PMID 29699616 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Electrical storm (ES), characterized by unrelenting recurrences of ventricular arrhythmias, is observed in approximatel… | Journal of the American College of Cardiology 2026-08-16 19:22:16 | Source |
| Tolerability, safety, and efficacy of atogepant versus topiramate in… Atogepant 60 mg · PMID 42492556 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Oral calcitonin gene-related peptide (CGRP) receptor antagonists such as atogepant have been approved for preventive tr… | The Lancet. Neurology 2026-08-16 19:22:14 | Source |
| Encephalopathy following subcutaneous administration of Brixadi® exte… Fentanyl · PMID 42571226 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Long-acting injectable buprenorphine is one option for the management of opioid use disorder. The United States Food an… | Toxicology reports 2026-08-16 19:22:13 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |